Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Rousseau, J. Just, E. Abrams, J. Casabona, Z. Stein, M. King (1997)
CCR5del32 in perinatal HIV-1 infection.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 16 4
E. Scala, G. D'Offizi, R. Rosso, O. Turriziani, R. Ferrara, A. Mazzone, G. Antonelli, F. Aiuti, R. Paganelli (1997)
C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection.Journal of immunology, 158 9
D. Zagury, A. Lachgar, V. Chams, L. Fall, J. Bernard, J. Zagury, B. Bizzini, A. Gringeri, E. Santagostino, J. Rappaport, M. Feldman, S. O’Brien, A. Burny, R. Gallo (1998)
C-C chemokines, pivotal in protection against HIV type 1 infection.Proceedings of the National Academy of Sciences of the United States of America, 95 7
T. O'Brien, N. Padian, T. Hodge, J. Goedert, S. O’Brien, M. Carrington (1998)
CCR-5 genotype and sexual transmission of HIV-1.AIDS, 12 4
C. Mackewicz, J. Levy, W. Cruikshank, H. Kornfeld, D. Center (1996)
Role of IL-16 in HIV replicationNature, 383
Kristiansen, Knudsen, Eugen‐Olsen (1998)
Chemokine Receptors and their Crucial Role in Human Immunodeficiency Virus Infection: Major Breakthroughs in HIV ResearchScandinavian Journal of Immunology, 48
K. Lim, H. Wan, P. Bozza, M. Resnick, D. Wong, W. Cruikshank, H. Kornfeld, D. Center, P. Weller (1996)
Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES.Journal of immunology, 156 7
W. Paxton, Rong Liu, Stanley Kang, Lijun Wu, T. Gingeras, Nathanial Landau, C. Mackay, R. Koup (1998)
Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.Virology, 244 1
C. Quillent, E. Oberlin, J. Braun, D. Rousset, G. González-Canali, P. Métais, L. Montagnier, J. Virelizier, F. Arenzana‐Seisdedos, A. Beretta (1998)
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 geneThe Lancet, 351
T. Wasik, J. Bratosiewicz, A. Wierzbicki, V. Whiteman, R. Rutstein, S. Starr, S. Douglas, D. Kaufman, A. Sison, M. Polansky, H. Lischner, D. Kozbor (1999)
Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission.Journal of immunology, 162 7
(1996)
Controlling HIV pathogenesis: the role of noncytotoxic anti-HIV activity of CD8 cells
(1997)
CCR5D32 in perinatal HIV infection
C. Amiel, E. Darcissac, M. Truong, J. Dewulf, M. Loyens, Y. Mouton, A. Capron, G. Bahr (1999)
Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression.The Journal of infectious diseases, 179 1
C. Li, Y. Yan, B. Shieh, C. Lee, R. Lin, Y. Chen (1997)
Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.Journal of the Formosan Medical Association = Taiwan yi zhi, 96 12
D. Center, H. Kornfeld, W. Cruikshank (1996)
Interleukin 16 and its function as a CD4 ligand.Immunology today, 17 10
S. McKenzie, G. Dallalio, M. North, P. Frame, R. Means (1996)
Serum chemokine levels in patients with non-progressing HIV infectionAIDS, 10
M. Jenkins, J. Mills, S. Kohl (1993)
Natural Killer Cytotoxicity and Antibody-Dependent Cellular Cytotoxicity of Human Immunodeficiency Virus–Infected Cells by Leukocytes from Human Neonates and AdultsPediatric Research, 33
R. Winchester, Yao-Tseng Chen, S. Rose, J. Selby, W. Borkowsky (1995)
Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method.Proceedings of the National Academy of Sciences of the United States of America, 92 26
W. Paxton, S. Martin, D. Tse, T. O'Brien, J. Skurnick, N. Vandevanter, N. Padian, J. Braun, D. Kotler, Steven Wolinsky, R. Koup (1996)
Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposuresNature Medicine, 2
S. Gasperini, R. Zambello, C. Agostini, L. Trentin, C. Tassinari, P. Cadrobbi, G. Semenzato, M. Cassatella (1998)
Impaired cytokine production by neutrophils isolated from patients with AIDSAIDS, 12
C. Mandl, S. Aberle, Judith Henkel, E. Puchhammer-Stöckl, F. Heinz (1998)
Possible influence of the mutant CCR5 allele on vertical transmission of HIV‐1Journal of Medical Virology, 55
M. Samson, F. Libert, B. Doranz, J. Rucker, C. Liesnard, C. Farber, S. Saragosti, C. Lapouméroulie, Jacqueline Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, Shalini Rana, Y. Yi, R. Smyth, R. Collman, R. Doms, G. Vassart, M. Parmentier (1996)
Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 382
F. Cocchi, A. Devico, A. Garzino-Demo, S. Arya, R. Gallo, P. Lusso (1995)
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T CellsScience, 270
Jay Levy, C. Mackewicz, Edward Barker (1996)
Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells.Immunology today, 17 5
R. Edelstein, L. Arcuino, J. Hughes, A. Melvin, K. Mohan, P. King, C. McLellan, B. Murante, B. Kassman, L. Frenkel (1997)
Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 16 4
F. Vitale, F. Bonura, A. Perna, F. Ajello, N. Romano (1997)
Serum rantes levels in HIV-positive individuals and in HIV-negative exposed health-care workersInfection, 25
Rong Liu, W. Paxton, Sunny Choe, Daniel Ceradini, S. Martin, R. Horuk, M. MacDonald, H. Stuhlmann, R. Koup, N. Landau (1996)
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 86
A. Garzino-Demo, A. Devico, F. Cocchi, R. Gallo (1998)
Beta-chemokines and protection from HIV type 1 disease.AIDS research and human retroviruses, 14 Suppl 2
T. Wasik, A. Wierzbicki, V. Whiteman, G. Trinchieri, H. Lischner, D. Kozbor (2000)
Association between HIV‐specific T helper responses and CTL activities in pediatric AIDSEuropean Journal of Immunology, 30
E. Stiene-Martin, C. Lotspeich-Steininger, J. Koepke (1992)
Clinical Hematology: Principles, Procedures, Correlations
S. Zanussi, M. D'andrea, C. Simonelli, U. Tirelli, P. Paoli (1996)
Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients.AIDS, 10 12
A. Luster (1998)
Chemokines--chemotactic cytokines that mediate inflammation.The New England journal of medicine, 338 7
M. Dean, M. Carrington, Christoph Winkler, G. Huttley, M. Smith, R. Allikmets, J. Goedert, S. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, S. O’Brien (1996)
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 273
A. Mangano, J. Kopka, M. Batalla, R. Bologna, L. Sen (2000)
Protective effect of CCR2-64I and not of CCR5-Δ32 and SDF1-3'A in pediatric HIV-1 infectionJournal of Acquired Immune Deficiency Syndromes, 23
(1997)
Frequency of CCR5D32 mutant allele in HIV-1–positive patients, female sex workers, and a normal population in Taiwan
J. Martinson, N. Chapman, D. Rees, Yantan Liu, J. Clegg (1997)
Global distribution of the CCR5 gene 32-basepair deletionNature Genetics, 16
(1998)
CCR5 genotype and sexual transmission of HIV-1
(1998)
Preparation of blood films for examination
B. Shieh, Y. Liau, Y. Yan, H. Sun, M. Chen, Y. Liu, N. Ko, C. Li (1999)
Alleles that may influence HIV-1 pathogenesis in Chinese subjects.AIDS, 13 3
The mutations in the CCR5 coding region, such as CCR5Δ32 and CCR5m303, that suppress the transmission of human immunodeficiency virus (HIV) type 1 do not exist in Chinese people. However, 9 Chinese subjects in Taiwan with histories of multiple sexual exposures to HIV remained uninfected, suggesting that certain anti-HIV factors do indeed exist. Experiments were therefore designed to investigate the immune mechanism that protects this cohort against HIV infection. Peripheral blood samples from these 9 subjects and 7 healthy people who had not been exposed to HIV were obtained for the quantitation of the levels for β-chemokines and interleukin 16 (IL-16) in serum samples or secreted by peripheral blood lymphocytes. Significantly higher serum levels for nearly all 3 β-chemokines, regulation on activation, normal T cell-expressed and secreted, macrophage inflammatory protein (MIP)–1α, and MIP-1β (P < .05, P < .05, and P = .05, respectively), but not IL-16, were detected in the 9 HIV-uninfected subjects as compared with control subjects. The result suggests that among the host genes and cellular factors thus far identified, β-chemokines are the major HIV-suppressive factors that protect Chinese people from infection with HIV.
Clinical Infectious Diseases – Oxford University Press
Published: Aug 1, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.